MUMBAI, India, Feb. 13 -- Intellectual Property India has published a patent application (202541124583 A) filed by Jerusalem College Of Engineering, Chennai, Tamil Nadu, on Dec. 10, 2025, for 'ai based non-invasive glucobreath analyser.'
Inventor(s) include B. Nivetha; V. Hariram; E. Pooja; and R. Harini.
The application for the patent was published on Feb. 13, under issue no. 07/2026.
According to the abstract released by the Intellectual Property India: "This project is an innovative, non-invasive device designed to revolutionize blood glucose monitoring for individuals with diabetes mellitus. Traditional finger-prick methods are often painful and inconvenient, impeding regular usage. GlucoBreath addresses these challenges by detecting glucose-related volatile organic compounds (VOCs) in exhaled breath through an advanced gas sensor array. The system integrates both hardware and. a machine learningbased software pipeline employing a hybrid Logistic Regression-AdaBoost ensemble model, achieving 90% accuracy in classifying diabetic and non-diabetic profiles during validation. This approach significantly reduces user discomfort and encourages long-term adherence, particularly benefiting pediatric, geriatric, and remote populations. It lowers costs and barriers associated with conventional monitoring, enabling broader accessibility in both clinical and home environments. Future developments aim to enhance real-time monitoring, personalized glucose trend analysis, and mobile integration to support remote health tracking and telemedicine."
Disclaimer: Curated by HT Syndication.
